Champions Oncology
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 210
- Market Cap
- -
- Introduction
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma
Not Applicable
Terminated
- Conditions
- Sarcoma
- Interventions
- Other: PDX drug sensitivity testing
- First Posted Date
- 2016-03-28
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- Champions Oncology
- Target Recruit Count
- 17
- Registration Number
- NCT02720796
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath